lysosomotropism | CMAC

lysosomotropism

Treatment of COVID19 with antimalarial medicines: clinical pharmacology analysis

The COVID-19 epidemic caused by the human coronovirus has led to completely new challenges for clinical pharmacology, and the healthcare system as a whole. By the time the infection started, there was no effective and safe therapy. In this regard, at …